New ETF Book by Larry Connors - Click here to read more
The agreement provides Bayer CropScience with non-exclusive access to aspects of Precision BioSciences' proprietary Directed Nuclease Editor (DNE) technology, which can be used to develop novel traits in plants.
In a release, the group noted that Precision BioSciences' DNE technology uses advanced protein engineering methods to produce rationally designed, obligate heterodimer endonucleases (enzymes) which have the ability to modify single sites within a large genome. Using DNE technology, crop researchers can insert multiple genes at a single site within a plant chromosome, thereby efficiently and precisely conferring desirable traits into plant species. This technology can thus streamline the trait development and breeding processes, and potentially accelerate a trait's time to market.
Under this agreement, Precision BioSciences provides Bayer CropScience with multiple DNE-engineered enzymes for use across the company's crop platforms.
"We are very pleased to be entering into this collaboration with Precision BioSciences for the genetic improvement of crops. Precision BioSciences brings to this partnership unique expertise. We now have access to an important tool for our research and development program that will enhance the speed and efficiency with which we bring valuable new technology solutions to our customers," said Joachim Schneider, Head of Business Unit BioScience at Bayer CropScience.
"We are thrilled to announce this collaboration with Bayer CropScience, an established innovator and leader in global agribusiness," said Derek Jantz, Vice President of Scientific Development at Precision BioSciences. "We are looking forward to our relationship with Bayer CropScience to develop novel products utilizing Precision BioSciences' DNE technology."
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.
((Comments on this story may be sent to health@closeupmedia.com))
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
